Much interest is being shown in fibrinogen as a possible cardiovascular risk factor.' The concept that fibrinogen is causally related to cardiovascular events is supported by several lines of evidence. Perhaps the strongest indication stems from seven prospective epidemiological trials2-all of which showed that fibrinogen predicts major cardiovascular events such as stroke and myocardial infarction. Clinical trials on survivors of a first myocardial infarction9 or stroke'0 also showed that fibrinogen was a risk factor for further cardiovascular disasters. Several plausible pathological mechanisms could explain this association': fibrinogen is an important clotting factor and it determines the flow properties of blood, represents a co-factor for platelet aggregation, and may cause atherosclerosis by direct effects on the arterial wall.
Acceptance that fibrinogen is a major cardiovascular risk factor will lead to attempts to lower its plasma concentration. Methods to achieve this are still in their infancy. Though dietary influences seem to be small,' there is a striking association between body weight and fibrinogen. I will review the data suggesting that weight loss might be one practical way of influencing fibrinogen concentrations.
Cross sectional data The baseline data of several epidemiological studies show a relation between fibrinogen and variables that reflect body weight. In the Scottish Heart Health Study" the body mass index (BMI) and fibrinogen were significantly correlated. The PROCAM data confirmed this association and the fact that it was stronger in men than in women'2; the Broca index, (a formula to estimate ideal 20 A similar Belgian study in 20 obese patients confirmed that obesity was associated with hyperviscosity and found a decrease in fibrinogen of 0-27 g/l over 6 months when the BMI fell from 32-8 (3d1) to 27-5) kg/M2.21 An Italian group put 40 obese patients on a diet of 1000-1400 kcal/day for one year.22 The fall in BMI from 36 (6) to 29 (4) kg/M2 was paralleled by a fall in fibrinogen concentration from 3 0 to 2'8 g/l. The same group studied obese children aged 7-14 years on a 1000-1400 kcal diet.23 Over 2 months the degree of overweight fell from 50 4 (149) to 34.4 (13-8)% and plasma fibrinogen fell from 4-6 to 4'2 g/l.
Last year an intriguing finding was reported from the United Kingdom24: an inverse correlation was found between the fibrinogen concentration of adult men and their weight at 1 year and at birth. If, for instance, the weight at 1 year was less than 18 pounds, the ageadjusted fibrinogen in adult life was 3'2 g/l, whereas it was only 2-9 g/l if the weight at one year was more than 26 pounds. Barker et al speculate that fibrinogen concentrations might be partly "programmed" in this early stage of life.24 When 13 healthy, non-overweight volunteers were put on two different diets,25 (containing 39% and 31% of total energy as fat) within two weeks there was a striking reduction in fibrinogen on the low fat diet (from 6-3 to 5-8 yumol/l). No change was seen during the control diet.
Total calories, fatty acid composition, and fibre content were identical in the two regimens. Fibrinogen concentration in 22 obese children aged 7-17 years fell considerably after only one month on a 1000 kcal/day diet.26 Body weight (mean (SD)) dropped from 96-7 (16-2) to 84'8 kg and fibrinogen fell from 4-2 (1'4) to 3 0 (0'9) g/l. The duration of the diet is not specified. When a very low calorie diet (524 kcal/day) was given to 23 obese women for 3 months followed by a maintenance diet of 900-100 kcal/day for a further 3 months.27 BMI decreased from 38'5 (1'6) to 33-7 (1.4) and fibrinogen fell from 2'8 to 2'6 g/l. The concentration of plasma fibrinogen did not change significantly during the first part of this regimen, it fell only in the second, less restricted phase. Finally when a large (n = 83) group of "healthy" obese individuals took an ill defined diet containing 10 g carbohydrates per day for 3 months,28 their mean (SD) fell from 83'3 (21A4) kg to 75-5 (18-3) kg and the fibrinogen concentration fell from 3-2 (0 9) to 2-9 (0'8) g/l.
Conclusions Though the results of all studies (table 1) are not universally consistent most implied that fibrinogen was lowered when body weight became normal in obese individuals. The extent of the fibrinogen effect is not uniform. There is no clear correlation between the decrease in fibrinogen concentrations and the duration of the diet (short programmes, however, seem to have no effect) or the calorie intake. Severe, but short term reductions in calorie intake do not induce significant changes in fibrinogen. Extrapolation from the Northwick Heart Health Study,2 in which the strength of the association of fibrinogen and coronary heart disease is typical of that in similar studies, suggests that a reduction of fibrinogen of 0-1 g/l corresponds to a reduction in risk of 15%.29 Thus the fibrinogen reduction that can be achieved by weight loss may be of considerable clinical importance. The fibrinogen-lowering effect of weight loss is likely to work in concert with the better known effects of weight normalisation (such as, reduction of hypertension, glucose tolerance, and hyperlipoproteinaemia) to reduce the risk of major cardiovascular events.
The present findings suggest that weight loss can reduce fibrinogen and may contribute to a lowering of the cardiovascular risk. But the apparent inconsistencies between studies need to be resolved by further trials. 
